Mastercard (NYSE: MA) appointed Mark Barnett as President of its European business, based in Brussels.
Hyloris Pharmaceuticals, a Liège, Belgium–based innovative specialty pharmaceutical company, raised €15m in funding.
Deliverect, a Ghent, Belgium-based startup streamlining the restaurant industry with its online food delivery management software, raised €16.25m in Series B funding.
InvestSuite, a Leuven, Belgium-based B2B WealthTech startup, raised €2m in funding.
Collibra, a Brussels, Belgium-based data intelligence company, raised $112.5m in funding at a post-money valuation of $2.3 billion.
The European Commission is calling for startups and SMEs with technologies and innovations that could help in treating, testing, monitoring or other aspects of the Coronavirus outbreak to apply urgently to the next round of funding from the European Innovation Council.
Based in Mechelen, Belgium, Customs4trade has created a comprehensive customs and trade compliance platform. The company has just raised an additional €3m in equity funding in a round which brought total funding raised to date to over €5.1m.
OncoDNA, a Gosselies, Belgium-based healthcare technology company focusedd on precision medicine, raised €19m ($20m) in Series B equity financing.
Nyxoah S.A., a Mont-Saint-Guibert, Belgium – based healthtech company developing neuromodulation-based therapeutic solutions for sleep disordered breathing conditions, raised €25m in financing.
Customs4trade, a Mechelen, Belgium-based creator of a comprehensive customs and trade compliance platform, raised an additional €3m in equity funding.
Catalent, Inc. (NYSE: CTLT), a Somerset, N.J.-based provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, acquired MaSTherCell Global, Inc., a technology-focused cell and gene therapy contract development and manufacturing organization to cell therapy innovators, for an aggregate of $315m in cash, subject to a customary […]
PDC*line Pharma, a Liege, Belgium and Grenoble, France-based clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, completed its €20m Series B round of financing.
Odoo, a Grand-Rosière, Belgium and San Francisco, CA-based leader in open source all-in-one business software, closed a $90m minority investment.
Atrium Sports, a NY- and Ottignies-Louvain-la-Neuve, Belgium-and technology platform for sports and video data content, acquired Synergy Sports Technology, a provider of data and video analytics tools for the NBA, the MLB and NCAA Division I-II-III basketball and Division I baseball.
Promethera Biosciences SA, a Mont-Saint-Guibert, Belgium-based global innovator in cell-based medicines and liver diseases, added €7.5m in funding to its recent €39.7m Series D financing.